Fixes Book Closure for Dividend & AGM
Glenmark Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 22, 2018 to September 28, 2018 (both days inclusive) for the purpose of Payment of Dividend & 40th Annual General Meeting (AGM) of the Company to be held on September 28, 2018.The dividend, if approved by the Members at the ensuing AGM, will be paid on or after October 03, 2018. 40Th Annual General Meeting - September 28, 2018
We have to inform you that the 40th Annual General Meeting (AGM) of Members of the Company is scheduled to be held on Friday, September 28, 2018 at 11.00 a.m. at Sunville Banquets & Conference Hall, 3rd floor, Dr. Annie Besant Road, Worli, Mumbai - 400 018. The copy of the notice will be sent to you in due course. Pursuant to the Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby... Glenmark Pharmaceuticals Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Glenmark Pharmaceuticals Ltd with respect to news article appearing on https://economictimes.indiatimes.com - August 10, 2018 titled "True North in talks to buy into Glenmark's API biz for Rs1500 cr". Glenmark Pharmaceuticals Ltd response is enclosed. Glenmark forms JV with True North for pain management, orthopaedic business
The business is valued at Rs 6.35 bn and Glenmark will continue to hold a stake in the new company Outcome of Board Meeting
Please find enclosed herewith, Management Discussion Analysis Report for the First Quarter ended June 30, 2018. The above is for your information and record. Announcement under Regulation 30 (LODR)-Meeting Updates
Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is to inform you that the Board of Glenmark Pharmaceuticals Limited (the "Company") at its meeting held today approved the transfer of the Company''s business of Active Pharmaceuticals Ingredient (API) to its wholly owned subsidiary, subject to the approval of the shareholders.... Announcement under Regulation 30 (LODR)-Meeting Updates
Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is to inform you that the Board of Glenmark Pharmaceuticals Limited (the "Company") at its meeting held today approved the transaction, the details of which are mentioned in the Annexure A.... Financial Result For June 30, 2018
Pursuant to Regulations 30 and 33 of the SEBI LODR, 2015, we wish to inform you that Board has today at its meeting approved the Unaudited Financial Results for the First Quarter ended June 30, 2018. The said meeting of the Board commenced at 02.00 p.m. and concluded at 06.15 p.m. The copy of the said results together with Limited Review Report and Press Release is enclosed herewith.... Clarification sought from Glenmark Pharmaceuticals Ltd
The Exchange has sought clarification from Glenmark Pharmaceuticals Ltd with respect to news article appearing on https://economictimes.indiatimes.com - August 10, 2018 titled True North in talks to buy into Glenmarks API biz for Rs1500 cr.The reply is awaited. Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Nomination & Remuneration Committee of the Company, at its meeting held on August 9, 2018 has granted 50,000 stock options under Employee Stock Options Scheme, 2016.